Centre for Immunobiology: Recent submissions
Now showing items 781-800 of 1121
-
The problem with repurposing: Is there really an alternative to Big Pharma for developing new drugs for multiple sclerosis?
(2015-01-01)©2014 Elsevier B.V. All rights reserved. If it is not feasible to develop licensed drugs to the stage that they can actually be prescribed for a new indication, can we justify, either ethically or economically, the undertaking ... -
Using the eSexual Health Clinic to access chlamydia treatment and care via the internet: a qualitative interview study.
(2018-06)OBJECTIVE: We developed the eSexual Health Clinic (eSHC), an innovative, complex clinical and public health intervention, embedded within a specialist sexual health service. Patients with genital chlamydia access their ... -
Signatures of Inflammation and Impending Multiple Organ Dysfunction in the Hyperacute Phase of Trauma
(Public Library of Science (PLoS), 2017-07-17) -
Catalog of Differentially expressed long non-coding RNA following activation of human and mouse innate immune response
(Frontiers Media, 2017-08-29)© 2017 Roux, Heward, Donnelly, Jones and Lindsay. Despite increasing evidence to indicate that long non-coding RNAs (lncRNAs) are novel regulators of immunity, there has been no systematic attempt to identify and characterize ... -
Seasonal temperature is associated with Parkinson's disease prescriptions: an ecological study.
(2017-12)The aim of this study is to test what effect the weather may have on medications prescribed to treat Parkinson's disease. Twenty-three years of monthly time, series data was sourced from the Pharmaceutical Benefits Scheme ... -
Real-Life Anti-Tumour Necrosis Factor Experience in > 500 Paediatric United Kingdom Inflammatory Bowel Disease Patients.
(2017-07-27)OBJECTIVES: To measure the effectiveness, safety and use of anti-Tumour necrosis Factor (TNF) therapy in paediatric inflammatory bowel disease (PIBD) in the United Kingdom (UK). METHODS: Prospective UK audit of patients ...